New generic Singulair could save asthma sufferers big bucks – ConsumerReports.org


MedPage Today

New generic Singulair could save asthma sufferers big bucks
ConsumerReports.org
Asthma and allergy sufferers who take Singulair (montelukast) will soon be able to slash their medication bills. Late last week, the Food and Drug Administration approved the first generic version of the popular drug. And within the first year or so
FDA approves generic versions of asthma, allergy drugDrug Store News
Merck: generic Singulair threat becomes realityEquities.com
First generic versions of Singulair receive FDA approval for treatment of News-Medical.net
WebMD –Medical Marketing and Media –MedPage Today
all 50 news articles »

View full post on asthma – Google News

First generic versions of Singulair receive FDA approval for treatment of … – News-Medical.net


MedPage Today

First generic versions of Singulair receive FDA approval for treatment of
News-Medical.net
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Montelukast is in
Teva asthma, allergy drug approved by FDAJerusalem Post
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesNASDAQ
Generic Singulair ApprovedWebMD
MedPage Today –Chicago Tribune –Columbus Dispatch
all 41 news articles »

View full post on asthma – Google News

FDA okays generic Singulair for asthma treatment – The Capitol Column


The Capitol Column

FDA okays generic Singulair for asthma treatment
The Capitol Column
The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesRTT News
FDA OKs generic SingulairChicago Tribune
Generic Singulair ApprovedWebMD
Globes –MedPage Today
all 37 news articles »

View full post on asthma – Google News

FDA Approves Generic Versions Of Singulair To Treat Asthma, Allergies – RTT News


MedPage Today

FDA Approves Generic Versions Of Singulair To Treat Asthma, Allergies
RTT News
(RTTNews) – The U.S. Food and Drug Administration said that on Friday it approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor
Generic Singulair ApprovedWebMD
FDA OKs generic SingulairChicago Tribune
FDA Greenlights Asthma Drug GenericsMedPage Today
Columbus Dispatch –Huffington Post
all 34 news articles »

View full post on asthma – Google News

FDA OKs generic Singulair – Chicago Tribune


MedPage Today

FDA OKs generic Singulair
Chicago Tribune
The Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co.'s best-selling product. The drugmakers, whose
Generic Singulair ApprovedWebMD
Generic asthma drugs receive FDA approvalColumbus Dispatch
FDA Greenlights Asthma Drug GenericsMedPage Today
FDA.gov –Huffington Post –Babble (blog)
all 33 news articles »

View full post on asthma – Google News

Generic Singulair Approved – WebMD


MedPage Today

Generic Singulair Approved
WebMD
3, 2012 — The FDA today gave 10 generic drugmakers approval to start making generic versions of Singulair (montelukast sodium), the popular asthma and allergy drug. Singulair, usually taken in the form of tablets, has been a blockbuster drug for Merck.
FDA Greenlights Asthma Drug GenericsMedPage Today
Generic Singulair: Cheaper Forms Of Asthma, Allergy Medication Approved By Huffington Post
HOT DAMN: Expensive Asthma/Allergy Medication Singulair Goes GenericBabble (blog)
FDA.gov –U.S. News & World Report
all 21 news articles »

View full post on asthma – Google News

In the Treatment of Asthma, Merck’s Singulair Accounts for More Than a Quarter … – MarketWatch (press release)

In the Treatment of Asthma, Merck's Singulair Accounts for More Than a Quarter
MarketWatch (press release)
Analysis of US patient-level claims data from Treatment Algorithms in Asthma also finds that more than half of newly diagnosed asthma patients that move to the second line of therapy within a year of diagnosis are treated with Singulair.

and more »

View full post on asthma – Google News